Performance and health economic evaluation of the Mount Sinai COVID-19 serological assay identifies modification of thresholding as necessary to maximise specificity of the assay
Stuart A Rushworth, Benjamin B Johnson, Karen Ashurst, Rose Davidson, Paige Paddy, Jayna J Mistry, Jamie A Moore, Charlotte Hellmich, Dylan R Edwards, Daniela Da Luz Afonso, Georgios Xydopoulos, Richard Goodwin, Javier Gomez, Reenesh Prakash, Samir Dervisevic, Richard Fordham, Kristian M Bowles, James G W Smith
doi: https://doi.org/10.1101/2020.06.11.20128306
Stuart A Rushworth
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Benjamin B Johnson
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Karen Ashurst
bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Rose Davidson
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
CSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Paige Paddy
CSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Jayna J Mistry
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Jamie A Moore
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Charlotte Hellmich
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
dDepartment of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Dylan R Edwards
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Daniela Da Luz Afonso
eHealth Economics Consulting, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Georgios Xydopoulos
eHealth Economics Consulting, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Richard Goodwin
fCOVID-19 Incident Management Team, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Javier Gomez
bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Reenesh Prakash
bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Samir Dervisevic
bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
Richard Fordham
eHealth Economics Consulting, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Kristian M Bowles
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
bMicrobiology Department, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
dDepartment of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
fCOVID-19 Incident Management Team, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom
James G W Smith
aNorwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7UQ, United Kingdom
Posted June 12, 2020.
Performance and health economic evaluation of the Mount Sinai COVID-19 serological assay identifies modification of thresholding as necessary to maximise specificity of the assay
Stuart A Rushworth, Benjamin B Johnson, Karen Ashurst, Rose Davidson, Paige Paddy, Jayna J Mistry, Jamie A Moore, Charlotte Hellmich, Dylan R Edwards, Daniela Da Luz Afonso, Georgios Xydopoulos, Richard Goodwin, Javier Gomez, Reenesh Prakash, Samir Dervisevic, Richard Fordham, Kristian M Bowles, James G W Smith
medRxiv 2020.06.11.20128306; doi: https://doi.org/10.1101/2020.06.11.20128306
Performance and health economic evaluation of the Mount Sinai COVID-19 serological assay identifies modification of thresholding as necessary to maximise specificity of the assay
Stuart A Rushworth, Benjamin B Johnson, Karen Ashurst, Rose Davidson, Paige Paddy, Jayna J Mistry, Jamie A Moore, Charlotte Hellmich, Dylan R Edwards, Daniela Da Luz Afonso, Georgios Xydopoulos, Richard Goodwin, Javier Gomez, Reenesh Prakash, Samir Dervisevic, Richard Fordham, Kristian M Bowles, James G W Smith
medRxiv 2020.06.11.20128306; doi: https://doi.org/10.1101/2020.06.11.20128306
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2952)
- Dermatology (250)
- Emergency Medicine (440)
- Epidemiology (12758)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4593)
- Geriatric Medicine (420)
- Health Economics (729)
- Health Informatics (2923)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (469)
- Neurology (4366)
- Nursing (237)
- Nutrition (640)
- Oncology (2274)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6949)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (439)
- Sports Medicine (385)
- Surgery (490)
- Toxicology (60)
- Transplantation (212)
- Urology (181)